EDR tripeptide
The glutamic acid–aspartic acid–arginine sequence is a very short peptide studied as a bioregulator.
Glu-Asp-Arg • EDR Tripeptide
Pinealon is a synthetic tripeptide studied for neural and oxidative-stress signaling. Sleep and cognitive interest persists, but evidence of benefit in humans remains limited.
Pinealon is a synthetic three-amino-acid peptide with the sequence glutamic acid–aspartic acid–arginine (EDR). It belongs to the short peptide bioregulator family studied largely by Russian research groups.
Researchers have explored Pinealon in cell and animal models of neural stress, aging, and cognition. Its small size and proposed effects on gene expression make it an interesting research compound, but these mechanisms do not establish clinical benefit.
Community interest centers on sleep, circadian rhythm, and mental clarity. Those outcomes have not been validated in modern randomized human trials, and nasal and SubQ use should be considered distinct routes.
For other neuropeptide guides, see Cerebrolysin and Dihexa.
The glutamic acid–aspartic acid–arginine sequence is a very short peptide studied as a bioregulator.
Laboratory studies investigate how EDR may interact with gene expression and stress-response pathways.
Preclinical work explores oxidative-stress defense and neuronal survival, without establishing human neuroprotection.
The link from these molecular observations to human cognition, REM sleep, or circadian outcomes remains unproven.
Most reported benefits come from cell and animal research or community observation, rather than controlled human outcomes.
Cell experiments found less oxidative-stress-related cell death. The result does not establish neuroprotection in people.
Animal studies have explored learning and orientation; controlled human cognitive testing is lacking.
Some community trackers report changes in dreams or REM estimates, without a controlled sleep-stage study.
Cell studies examine damage markers and stress-response signaling; the clinical importance remains uncertain.
Sign in or create a free account to view this content.
Our reported diluent preference is 50% sterile, preservative-free 0.9% saline and 50% bacteriostatic 0.9% sodium chloride. The bacteriostatic component contains a preservative. Use a suitable metered bottle and clean handling.
The example contains 10mg Pinealon in 5mL final liquid volume, using equal parts of the two diluents: 2.5mL sterile saline and 2.5mL bacteriostatic sodium chloride. This gives 2mg/mL.
At a measured 0.1mL per spray, 2mg/mL delivers 200mcg per spray. Check the bottle specification and actual output; another pump volume changes the amount per spray.
Keep refrigerated and protected from light according to the formulation instructions. Record the prep date in your research journal.
Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.
Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.
Swirl or roll the vial until the contents dissolve; do not shake.
Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.
These are community comparisons and research-interest pairings; combined effects have not been established.
Both appear in circadian and aging discussions. Tracking each separately makes it easier to tell whether Pinealon adds anything to the experience.
A cognitive-interest pairing: Semax is discussed for focus, while Pinealon is positioned as slower background neural support.
Selank appears in stress and calm-focus discussions. Any subjective change in a combination would be difficult to attribute.
Adamax is commonly sought for a more noticeable cognitive experience; Pinealon’s effects, if any, may be subtler.
Published human safety data are sparse. Neither a reliable adverse-event rate nor long-term safety profile has been established.
We have tried Pinealon twice. The first nasal cycle produced no noticeable change in sleep, mood, or cognition. For the second, we moved dosing to the morning, got sunlight afterward, and tracked sleep with an Oura ring. REM estimates increased a little and dreams were more vivid, but we did not feel better rested or notice a meaningful cognitive lift.
That leaves us mixed and leaning toward a skip. The research idea is interesting, yet the result in our own experience was too subtle to justify much enthusiasm. For sleep and circadian interest we would look at Epitalon first; for a more noticeable cognitive experiment, Adamax. Pinealon keeps its C grade because the theory is stronger than our practical result.
Peptide Protocols
Send us a message and we’ll reply to the email address you provide.